Home >> Marketplace Archives >> FDA clears test to detect antibodies to HMGCR

FDA clears test to detect antibodies to HMGCR

Print Friendly, PDF & Email

September 2018—Inova Diagnostics announced FDA clearance of its Quanta Flash HMGCR for use on its Bio-Flash random access chemiluminescent system. Quanta Flash HMGCR is a semiquantitative chemiluminescence immunoassay for the determination of IgG autoantibodies against HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase) antigen in human serum. The presence of anti-HMGCR antibodies, in conjunction with clinical findings and other laboratory tests, is an aid in the diagnosis of idiopathic inflammatory myopathy.

Inova Diagnostics, 858-586-9900


Check Also

Inova launches next-gen EIA/IFA processor

Jan. 2, 2018—Inova Diagnostics announced the worldwide launch of its Quanta-Lyser 3000, a fully automated enzyme-linked immunoassay …